相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Signal Transducer and Activator of Transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) Balance Controls Cytotoxicity and IL-10 Expression in Decidual-Like Natural Killer Cell Line NK-92
Anne Braunschweig et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Wenjun Ouyang et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70
Mark C. Heckel et al.
CELLULAR IMMUNOLOGY (2011)
Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta 1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response?
Mahboobeh Razmkhah et al.
CELLULAR IMMUNOLOGY (2011)
Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
Ashutosh Chaudhry et al.
IMMUNITY (2011)
Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3- and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
Samuel Huber et al.
IMMUNITY (2011)
Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1
Ryan L. Brunsing et al.
IMMUNOLOGY (2011)
Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: Induction of IL-10 expression in the stromal layers
Mariana Lazarini et al.
LEUKEMIA RESEARCH (2011)
Computational Analysis of Simulated SNP Interactions Between 26 Growth Factor-Related Genes in a Breast Cancer Association Study
Cheng-Hong Yang et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2011)
NDRG2-mediated Modulation of SOCS3 and STAT3 Activity Inhibits IL-10 Production
Eun Byul Lee et al.
Immune Network (2011)
Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate
Ulrich Joimel et al.
BMC CANCER (2010)
Hypomethylation of the interleukin-10 gene in breast cancer tissues
Keun Su Son et al.
BREAST (2010)
Association of interleukin-10 gene variation with breast cancer prognosis
Armin Gerger et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
GM-CSF, IL-1α, IL-β, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1α and TNF-α
G. PANG et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
IL-10 alters prolactin receptor activity emulating that during breast cancer
Sonali Paul et al.
CYTOKINE (2010)
IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines
Li Zeng et al.
CYTOKINE (2010)
Biology of interleukin-10
Robert Sabat et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population
Fanjun Kong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation
A. Carpi et al.
CURRENT CANCER DRUG TARGETS (2009)
c-Maf Regulates IL-10 Expression during Th17 Polarization
Jiangnan Xu et al.
JOURNAL OF IMMUNOLOGY (2009)
Breast Cancer Risk Associated With Polymorphisms of IL-1RN and IL-4 Gene in Indian Women
Rituraj Konwar et al.
ONCOLOGY RESEARCH (2009)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Chemotherapy targeted to cancer tissue potentiates antigen-specific immune response induced by vaccine for in vivo antigen loading and activation of dendritic cells
Hakan Akbulut et al.
MOLECULAR THERAPY (2008)
Cytokine comparisons between women with breast cancer and women with a negative breast biopsy
Debra E. Lyon et al.
NURSING RESEARCH (2008)
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Brian M. Nolen et al.
BREAST CANCER RESEARCH (2008)
TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2007)
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells
Amit Awasthi et al.
NATURE IMMUNOLOGY (2007)
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells
Denise C. Fitzgerald et al.
NATURE IMMUNOLOGY (2007)
TH1 cells control themselves by producing interleukin-10
Anne O'Garra et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-β expression
Charles Pilette et al.
JOURNAL OF IMMUNOLOGY (2007)
Oestrogen receptor negative breast cancers exhibit high cytokine content
Carine Chavey et al.
BREAST CANCER RESEARCH (2007)
Significance of interleukin-6 (IL-6) in breast cancer (review)
Heike Knuepfer et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo et al.
BREAST CANCER RESEARCH (2007)
Relationship between IL-10 and tumor markers in breast cancer patients
Leticia Llanes-Fernandez et al.
BREAST (2006)
Use of statistics to assess the global burden of breast cancer
DM Parkin et al.
BREAST JOURNAL (2006)
Interleukin-10 and the immune response against cancer: a counterpoint
S Mocellin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Dendritic cell dysfunction in cancer:: A mechanism for immunosuppression
A Pinzon-Charry et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Δ12,14-prostaglandin J2
JD Ji et al.
RHEUMATOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk
U Langsenlehner et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility
K Kingo et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2005)
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy
L Pusztai et al.
CYTOKINE (2004)
Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro
Xiao-Zhong Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Cytokine gene polymorphisms and breast cancer susceptibility and prognosis
KC Smith et al.
EUROPEAN JOURNAL OF IMMUNOGENETICS (2004)
Cytokines in cancer immunity and immunotherapy
MJ Smyth et al.
IMMUNOLOGICAL REVIEWS (2004)
Interleukin-10 suppression of myeloid cell activation - a continuing puzzle
LM Williams et al.
IMMUNOLOGY (2004)
Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis - Association with dephosphorylation of STAT3
Y Kalechman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Interleukin-10 and related cytokines and receptors
S Pestka et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-α genes
L Giordani et al.
CLINICAL CHEMISTRY (2003)
Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells
DL Commeren et al.
IMMUNOLOGY (2003)
Interleukin-10 therapy - Review of a new approach
K Asadullah et al.
PHARMACOLOGICAL REVIEWS (2003)
MHC class I antigens, immune surveillance, and tumor immune escape
A Garcia-Lora et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Interleukin-10 and the regulation of mitogen-activated protein kinases:: are these signalling modules targets for the anti-inflammatory action of this cytokine?
JJ Haddad et al.
CELLULAR SIGNALLING (2003)
Regulatory role of p53 in experimental autoimmune encephalomyelitis
Y Okuda et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Cutting edge: Immune cells as sources and targets of the IL-10 family members?
K Wolk et al.
JOURNAL OF IMMUNOLOGY (2002)
Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation
ML Garcia-Hernández et al.
IMMUNOLOGY (2002)
Cutting edge: IL-10-producing CD4(+) T cells mediate tumor rejection
BM Segal et al.
JOURNAL OF IMMUNOLOGY (2002)
IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages
S Hashimoto et al.
JOURNAL OF IMMUNOLOGY (2001)
Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ
S Fujii et al.
BLOOD (2001)
Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients
E Kovacs
BIOMEDICINE & PHARMACOTHERAPY (2001)
A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes
F Geissmann et al.
JOURNAL OF IMMUNOLOGY (2001)
Paclitaxel causes mouse splenic lymphocytes to a state hyporesponsive to lipopolysaccharide stimulation
M Lee et al.
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY (2000)
分享论文
